Navigation Links
Survey of Oncologists Reveals 98.9% of Physicians Experienced Cancer Drug Shortages in Last 12 Months
Date:11/15/2012

WASHINGTON, Nov.15, 2012 /PRNewswire/ -- The Community Oncology Alliance (COA), a non-profit organization dedicated to preserving and fostering community cancer care, announced the results of a drug shortage survey of 200 member practices representing 525 physicians across the United States.  98.9% of the respondents reported experiencing a drug shortage in the last year.   Survey participants indicated that the cancer progressed more quickly in more than 60 percent of patients as a result of the drug shortages, and more than 70 percent of patients had more severe side effects as a result of drug shortages.  

Almost half of those surveyed reported seeing more than one patient per day affected by a drug shortage and 58.2% indicate the shortage in cancer care drugs is increasing.  Over 80% of the patients and over 90% of the practices affected by a cancer drug shortage also experienced a more severe financial burden.

"The root cause of the drug shortage is economic," said Ted Okon, executive director of COA.  "The Medicare system for reimbursing for cancer drugs has created pricing instability.   That has resulted in disincentives for manufactures to produce these low-cost but vital generic cancer drugs, as well as to invest in manufacturing facilities for these products."

In addition to issues of optimal treatment, drug substitutions made because of a shortage often result in patients facing significantly higher costs.  

"When treating ovarian cancer, a commonly used drug is leucovorin.  The cost to Medicare is $35 per dose; the patient co-payment is $9.  But leucovrin is a generic drug and in short supply," says Dr. Patrick Cobb, an oncologist at the Frontier Cancer Centers and Blood Institute, Billings, Montana, and COA past president.  "The substitute is a branded drug that is readily available.  The cost to Medicare for a dose of the branded drug is $2,000 and the cost to the patient is $520.  This is an unacceptable consequence of the drug shortage crisis."

The complete survey results and comments from respondents are available at http://www.communityoncology.org/site/coa-studies.htm.

About Community Oncology Alliance (COA)
Formed in 2003 by community oncologists, COA is a non-profit organization dedicated solely to community oncology, where four out of five Americans with cancer are treated.   COA has mobilized community oncology to become more politically active, and increased awareness on Capitol Hill about the community cancer care delivery system. Additionally, COA has brought together community oncology practices from across the country to share information in order to enhance the effectiveness and efficiency of the cancer care they provide to their patients. COA also has a multi-stakeholder group involved with the implementation of the Oncology Medical Home, a cancer care model that fosters quality and value in cancer care. More information can be found at www.communityoncology.org.                                                      


'/>"/>
SOURCE Community Oncology Alliance
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
2. As Smartphone Usage Expands, Survey Says Nurses and Nursing Students Want Mobile Access to Credible Drug Data
3. Survey Shows eContent Critical to Corporate Strategies
4. Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry
5. Global Pharmaceutical Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry
6. Global Medical Devices Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry
7. "AWAKEN" Survey Finds Only 50 Percent of Americans Understand Significant Health Impact of Narcolepsy, and Many Physicians Not Comfortable Diagnosing the Sleep Disorder
8. Pharma Execs Continue Looking For Growth Opportunities In Spite Of Increasing Regulatory Challenges: KPMG Survey
9. Supplier Marketing Spend Activity, Marketing and Sales Behaviors and Strategies in the Medical Devices Industry - 2012-2013 : Survey Intelligence
10. Buyer Spend Activity and Procurement Behaviors and Strategies in the Pharmaceutical Industry - 2012-2013 : Survey Intelligence
11. Hologic Breast Tomosynthesis (3D Mammography) System Places First in KLAS Annual Survey of Mammography Equipment Users
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2017)... 2017  A new tight-tolerance microextrusion medical tubing ... materials, is being launched by Natvar, a Tekni-Plex ... in recent years to service a wide variety ... More expensive materials such as glass and fluoropolymers ... to their ability to consistently hold tolerances. This ...
(Date:5/3/2017)... 2017  Kalorama Information notes that transplant diagnostics ... year and this is projected to continue to ... (HSCT) or bone marrow transplants require histocompatibility between ... for this task. This according to a new ... The various PCR-based methodologies, Sanger sequencing and NGS ...
(Date:5/2/2017)... NEW YORK and LONDON ... distributor of market intelligence, MarketResearch.com is pleased to announce ... Consulting AB that allows for the marketing and ... market analyses through the MarketResearch.com website. The ... access to complete product descriptions and tables of contents ...
Breaking Medicine Technology:
(Date:5/27/2017)... ... May 27, 2017 , ... Most us are familiar with ... new study from the Osteoarthritis Initiative shows that certain people who experience ... this in advance may give doctors the opportunity to treat patients before the problem ...
(Date:5/26/2017)... ... May 26, 2017 , ... Leading CEOs from ... May 30th and 31st at The Four Seasons Hotel Boston. , The ... life sciences, offering exclusive access to key decision makers who influence deal making ...
(Date:5/26/2017)... Clara, Calif. (PRWEB) , ... May 26, 2017 ... ... announces the integration of the CareFusion NOX-T3 portable sleep monitor with its Somnoware ... provides a consistent, browser-based interface for diagnostic device operations. With this platform, initializing ...
(Date:5/26/2017)... ... May 26, 2017 , ... via ... antimicrobial, mesh back 24/7 task chair specifically designed for clinical areas. Genie Copper ... thrilled to partner with Cupron® to provide customers with a game changing chair ...
(Date:5/26/2017)... ... May 26, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... focusing on the Peace Agreements being discussed by President Donald Trump and the rest ... to try to speed up peace talks in the continuous battle between Israel and ...
Breaking Medicine News(10 mins):